Tom Lee Just Made A SHOCKING Prediction For 2026

Key Concepts

• Permabull: A consistently optimistic investor, believing in long-term market growth despite short-term fluctuations.
• Fed Put: The belief that the Federal Reserve will intervene to support markets during downturns by lowering interest rates or implementing other easing policies.
• White House Put: The expectation that government policies will be favorable to businesses, providing a supportive environment for investment.
• Animal Spirits: Investor confidence and willingness to take risks, driving economic activity.
• ISM Manufacturing Index: An economic indicator reflecting the health of the manufacturing sector; a reading below 50 indicates contraction.
• Nucleosomotics: Valition RX’s proprietary technology for detecting disease biomarkers based on chromatin fragments.
• Liquid Biopsy: A blood test used to detect cancer and other diseases by analyzing biomarkers.
• NETs (Neutrophil Extracellular Traps): Structures released by immune cells that, when dysregulated, are associated with sepsis and other diseases.

---

Market Outlook & Tom Lee’s Predictions

Tom Lee, a long-standing bullish investor, is predicting a 10-15% market drawdown in the first half of 2026, mirroring the volatility seen in 2025 (a bear and bull market within the same year). He attributes this potential decline to the continued hawkish monetary policy of current Federal Reserve Chair Jerome Powell, which has suppressed “business animal spirits” despite market gains. He notes the ISM Manufacturing Index has been below 50 for over three years, indicating prolonged economic contraction due to the Fed’s rate hikes. However, Lee anticipates a significant shift in May 2026 with the appointment of a new, more dovish Fed Chair, triggering a market recovery.

Lee argues that Wall Street’s skepticism is actually a bullish signal, as markets tend to climb a “wall of worry” and peak on optimism. He points out investors have endured six “extinction events” (COVID, supply chain disruptions, inflation, rate hikes, tariffs, geopolitical shocks) in four years, leading to risk aversion and a disconnect between market performance and investor sentiment. He believes the current market environment differs significantly from the 1990s tech bubble, characterized by unrealistic return expectations and inflated valuations.

The Two “Puts” Supporting the Bull Case

Lee identifies two key factors that will act as “puts” – safety nets – for the market:

1. The Fed Put: He believes the incoming Fed Chair in May 2026 will adopt a significantly more dovish stance, cutting rates and supporting risk assets. Lower rates expand multiples on risk assets, potentially increasing the value of revenue significantly.
2. The White House Put: The current administration is pursuing pro-business regulations, particularly in AI, and simplifying infrastructure development. He anticipates a gridlocked Congress following the midterms, resulting in regulatory certainty for the next two years – a scenario favored by half of equity investors.

Undervalued Sectors: Small Caps & Financials

Lee highlights two sectors as particularly undervalued:

• Small Caps: He believes real earnings growth is expected in small-cap companies, but investment flows remain at record lows. He anticipates a surge in performance once the Fed begins cutting rates and the business cycle expands.
• Financials: Lee makes a bold claim that banks are currently undervalued, arguing they are evolving into technology companies. He uses the example of JP Morgan, suggesting AI implementation can drastically reduce labor costs. He proposes that financial companies should trade at tech-like price-to-earnings (P/E) multiples, potentially reaching a P/E of 30 compared to the historical average of 10. He specifically calls out JP Morgan, Goldman Sachs, and Morgan Stanley as banks positioned for this transformation.

AI & Crypto Outlook

Regarding AI, Lee describes the current phase as “bleeding edge,” where technology precedes practical applications, similar to the early days of mobile technology. He envisions a future where AI enhances the productivity of the 130 million US workers, representing a multi-trillion-dollar market.

On cryptocurrency, Lee remains optimistic, stating “the best years are definitely ahead.” He notes that there are only 4 million Bitcoin wallets with $10,000 or more, compared to 900 million IRA and brokerage accounts globally with similar balances, indicating significant growth potential. He highlights favorable legislation and increased Wall Street interest in blockchain technology as positive developments.

Valition RX (VNRX) – Early Disease Detection

The video features a sponsored segment on Valition RX (VNRX), a diagnostics company focused on early disease detection. Valition’s technology, NU.Q, utilizes nucleosomotics to detect biomarkers of cancer and sepsis in blood samples. Key features include:

• Early Detection: The technology aims to identify diseases before symptoms appear, significantly improving survival rates (e.g., 90%+ survival for stage 1 cancer vs. single digits for stage 4).
• Low Cost & Speed: NU.Q is designed to be affordable and provide results in 10-45 minutes, unlike traditional tests that can take days or weeks and cost significantly more.
• Platform Agnostic: The test can be run on existing lab equipment, facilitating widespread adoption.
• Strong IP Protection: Valition holds 71 granted patents extending to 2044.
• Licensing Model: The company has a proven licensing model, exemplified by a $23 million deal with Anttech.
• Multiple Applications: Valition is targeting cancer screening (NU.Qancer), sepsis detection (NU.Qnets), veterinary diagnostics (NU.Qvet), and research tools (NU.Qdiscover), representing a combined $8 billion total addressable market.
• NETs Technology: Their technology for detecting NETs (Neutrophil Extracellular Traps) shows promise for diagnosing and monitoring sepsis, as well as other conditions like autoimmune diseases.

Conclusion

Tom Lee’s outlook suggests a turbulent first half of 2026, but ultimately a bullish long-term perspective. He emphasizes the importance of the upcoming Fed Chair appointment, the supportive regulatory environment, and the potential for undervalued sectors like small caps and financials to outperform. The video also highlights Valition RX as a company positioned to capitalize on the growing demand for early disease detection through its innovative and accessible diagnostic platform. The core message is to prepare for volatility but remain optimistic about the overall market trajectory.